On 28 Jan 2020, Agile Therapeutics, Inc. stock recognized change of 1020.00% far from 52-week low rate and recently situated relocation of 9.50% off 52-week high rate. AGRX stock has been tape-recorded 63.78% away from 50 day moving average and 147.51% far from 200 day moving average. Moving closer, we can see that shares have been trading 35.71% off 20-day moving average.
AGRXs shares are at 243.86% for the quarter and driving a 361.72% return throughout the previous year and is now at 56.80% given that this point in 2018. The average volatility for the week at 11.59% and for month was at 9.03%. The Healthcare sector business, Agile Therapeutics, Inc. saw modification of 14.96% to $3.92 along volume of 5510868 shares in recent session compared to an average volume of 6264.14 K.
Agile Therapeutics, Inc. (AGRX), a womens health care business, recently reported the visit of Kimberly Whelan as Vice President of Market Access. Ms. Whelan has more than 35 years of experience in the health care market working in financing, sales, marketing, organisation development, and handled markets.
At the exact same time, Agile has actually filled two extra positions to additional enhance its financing and marketing abilities. Charles S. Grass, CMA, has actually been named Senior Director, Finance and Matthew Riley has been called Product Manager.
Ms. Whelan is responsible for supervising the development and execution of Agiles market access method in preparation for the possible commercialization of the businesss lead product prospect, Twirla ® (AG200-15), which has a PDUFA objective date of February 16, 2020.